The Federal Circuit limits the reach of the on sale bar and provides guidance to pharmaceutical companies that rely on the use of contract manufacturers. Bruce Haas and Lauren Zuffante discuss.
July 28, 2020
July 14, 2020
July 09, 2020
July 31, 2020
July 27, 2020
July 23, 2020